News
February 1, 2008 - Stentys' bifurcated stent was successfully implanted recently into a 49-year-old male patient at the ThoraxCenter, Erasmus Medical Center, Rotterdam, the Netherlands, marking the sixth successful implantation of the Stentys bifurcated stent platform.
January 31, 2008
News
February 1, 2008 - Medtronic Inc. has received approval from the FDA for the Endeavor Zotarolimus-Eluting Coronary Stent ...
January 31, 2008News
January 30, 2008 - TopSpin Medical Inc. installed the Cathamaran Intravascular MRI System at ZOL Hospital in Belgium, marking the first installation of the system and its entrance in a study on vulnerable plaque.
January 29, 2008Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026News
January 30, 2008 - Cardica Inc.’s C-Port Distal Anastomosis Systems will be used in two courses to train cardiothoracic ...
January 29, 2008News
January 30, 2008 - TopSpin Medical Inc. announced the first commercial installation of the Cathamaran Intravascular MRI System at ZOL Hospital, Genk, Belgium, with the first procedures performed on Jan. 16.
January 29, 2008News
January 30, 2008 - Cardiac Science Corp. won two contracts to supply Powerheart automated external defibrillators (AEDs) ...
January 29, 2008Sponsored Content
Feature | Cardiac Imaging
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
March 13, 2026News
January 30, 2008 - Aporo Biomedical signed an exclusive global licensing agreement with mNEMOSCIENCE GmbH for its proprietary biodegradable shape memory polymers (BIO-SMP), enabling Aporo to offer devices with biodegradable closure features for treating structural heart diseases such as PFO and ASD.
January 29, 2008News
January 30, 2008 - NightHawk Radiology is the exclusive radiology provider for the High-Risk Plaque Initiative, called ...
January 29, 2008News
January 30, 2008 - Iroko Pharmaceuticals (Iroko) acquired all non-U.S. commercial rights to Aggrastat (tirofiban HCl) from Merck & Co. Inc., used for patients undergoing coronary angioplasty or atherectomy to prevent cardiac ischemic complications, in a move Iroko hopes will strengthen its presence in the cardiovascular market.
January 29, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
January 29, 2008 - Edwards Lifesciences Corp. received conditional approval from the FDA for the addition of the ...
January 28, 2008News
January 28, 2008 - A new multi-center, international clinical trial that compares the safety and effectiveness of thoracic endovascular aortic repair (TEVAR) to open surgery for descending thoracic aortic aneurysms (TAA), indicates that TEVAR (the less invasive endovascular graft) is a promising treatment option for many patients.
January 28, 2008Technology
Power Medical Interventions Inc. said the FDA cleared its 510(k) application for marketing its intelligent iDrive ...
January 28, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025Technology
NEC Electronics America Inc. introduced two new color, 21.3-inch diagonal amorphous-silicon thin-film transistor (TFT) liquid-crystal display (LCD) modules for medical imaging applications.
January 28, 2008Feature | Dave Fornell
February 2008 - The body regulates its core temperature by reducing the blood flow to the extremities, but anesthesia ...
January 28, 2008News
January 29, 2008 - The Medicines Company received the European Commission�s authorization of an expanded use for ...
January 28, 2008